Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease (Molecular Psychiatry, (2018), 23, 4, (963-972), 10.1038/mp.2017.81)

M. A.A. DeMichele-Sweet; E. A. Weamer; L. Klei; D. T. Vrana; D. J. Hollingshead; H. J. Seltman; R. Sims; T. Foroud; I. Hernandez; S. Moreno-Grau; L. Tárraga; M. Boada; A. Ruiz; J. Williams; R. Mayeux; O. L. Lopez; E. L. Sibille; M. I. Kamboh; B. Devlin; R. A. Sweet

doi:10.1038/s41380-019-0373-9

Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease (Molecular Psychiatry, (2018), 23, 4, (963-972), 10.1038/mp.2017.81)

M. A.A. DeMichele-Sweet, E. A. Weamer, L. Klei, D. T. Vrana, D. J. Hollingshead, H. J. Seltman, R. Sims, T. Foroud, I. Hernandez, S. Moreno-Grau, L. Tárraga, M. Boada, A. Ruiz, J. Williams, R. Mayeux, O. L. Lopez, E. L. Sibille, M. I. Kamboh, B. Devlin, R. A. Sweet

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Abstract

In the original version of this article, the following acknowledgements were accidentally omitted: "Genetic and Environmental Risk in AD Consortium 1 (UK): Data used in the preparation of this article were obtained from the Genetic and Environmental Risk for Alzheimer’s Disease (GERAD1) Consortium [1]. The GERAD1 sample comprised up to 3941 AD cases and 7848 controls. A subset of this sample has been used in this study. Cardiff University was supported by the Wellcome Trust, Medical Research Council (MRC) and/or Alzheimer’s Research UK (ARUK) and the Welsh Assembly Government.

Original language	English (US)
Pages (from-to)	3109-3111
Number of pages	3
Journal	Molecular psychiatry
Volume	25
Issue number	11
DOIs	https://doi.org/10.1038/s41380-019-0373-9
State	Published - Nov 1 2020
Externally published	Yes

ASJC Scopus subject areas

Molecular Biology
Cellular and Molecular Neuroscience
Psychiatry and Mental health

Access to Document

10.1038/s41380-019-0373-9

Cite this

DeMichele-Sweet, M. A. A., Weamer, E. A., Klei, L., Vrana, D. T., Hollingshead, D. J., Seltman, H. J., Sims, R., Foroud, T., Hernandez, I., Moreno-Grau, S., Tárraga, L., Boada, M., Ruiz, A., Williams, J., Mayeux, R., Lopez, O. L., Sibille, E. L., Kamboh, M. I., Devlin, B., & Sweet, R. A. (2020). Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease (Molecular Psychiatry, (2018), 23, 4, (963-972), 10.1038/mp.2017.81). Molecular psychiatry, 25(11), 3109-3111. https://doi.org/10.1038/s41380-019-0373-9

DeMichele-Sweet, MAA, Weamer, EA, Klei, L, Vrana, DT, Hollingshead, DJ, Seltman, HJ, Sims, R, Foroud, T, Hernandez, I, Moreno-Grau, S, Tárraga, L, Boada, M, Ruiz, A, Williams, J, Mayeux, R, Lopez, OL, Sibille, EL, Kamboh, MI, Devlin, B & Sweet, RA 2020, 'Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease (Molecular Psychiatry, (2018), 23, 4, (963-972), 10.1038/mp.2017.81)', Molecular psychiatry, vol. 25, no. 11, pp. 3109-3111. https://doi.org/10.1038/s41380-019-0373-9

@article{4fd7ff0e0907443f816caaace4de6867,

title = "Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease (Molecular Psychiatry, (2018), 23, 4, (963-972), 10.1038/mp.2017.81)",

abstract = "In the original version of this article, the following acknowledgements were accidentally omitted: {"}Genetic and Environmental Risk in AD Consortium 1 (UK): Data used in the preparation of this article were obtained from the Genetic and Environmental Risk for Alzheimer{\textquoteright}s Disease (GERAD1) Consortium [1]. The GERAD1 sample comprised up to 3941 AD cases and 7848 controls. A subset of this sample has been used in this study. Cardiff University was supported by the Wellcome Trust, Medical Research Council (MRC) and/or Alzheimer{\textquoteright}s Research UK (ARUK) and the Welsh Assembly Government.",

author = "DeMichele-Sweet, {M. A.A.} and Weamer, {E. A.} and L. Klei and Vrana, {D. T.} and Hollingshead, {D. J.} and Seltman, {H. J.} and R. Sims and T. Foroud and I. Hernandez and S. Moreno-Grau and L. T{\'a}rraga and M. Boada and A. Ruiz and J. Williams and R. Mayeux and Lopez, {O. L.} and Sibille, {E. L.} and Kamboh, {M. I.} and B. Devlin and Sweet, {R. A.}",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Nature Limited.",

year = "2020",

month = nov,

day = "1",

doi = "10.1038/s41380-019-0373-9",

language = "English (US)",

volume = "25",

pages = "3109--3111",

journal = "Molecular psychiatry",

issn = "1359-4184",

publisher = "Springer Nature",

number = "11",

}

TY - JOUR

T1 - Correction

T2 - Genetic risk for schizophrenia and psychosis in Alzheimer disease (Molecular Psychiatry, (2018), 23, 4, (963-972), 10.1038/mp.2017.81)

AU - DeMichele-Sweet, M. A.A.

AU - Weamer, E. A.

AU - Klei, L.

AU - Vrana, D. T.

AU - Hollingshead, D. J.

AU - Seltman, H. J.

AU - Sims, R.

AU - Foroud, T.

AU - Hernandez, I.

AU - Moreno-Grau, S.

AU - Tárraga, L.

AU - Boada, M.

AU - Ruiz, A.

AU - Williams, J.

AU - Mayeux, R.

AU - Lopez, O. L.

AU - Sibille, E. L.

AU - Kamboh, M. I.

AU - Devlin, B.

AU - Sweet, R. A.

PY - 2020/11/1

Y1 - 2020/11/1

N2 - In the original version of this article, the following acknowledgements were accidentally omitted: "Genetic and Environmental Risk in AD Consortium 1 (UK): Data used in the preparation of this article were obtained from the Genetic and Environmental Risk for Alzheimer’s Disease (GERAD1) Consortium [1]. The GERAD1 sample comprised up to 3941 AD cases and 7848 controls. A subset of this sample has been used in this study. Cardiff University was supported by the Wellcome Trust, Medical Research Council (MRC) and/or Alzheimer’s Research UK (ARUK) and the Welsh Assembly Government.

AB - In the original version of this article, the following acknowledgements were accidentally omitted: "Genetic and Environmental Risk in AD Consortium 1 (UK): Data used in the preparation of this article were obtained from the Genetic and Environmental Risk for Alzheimer’s Disease (GERAD1) Consortium [1]. The GERAD1 sample comprised up to 3941 AD cases and 7848 controls. A subset of this sample has been used in this study. Cardiff University was supported by the Wellcome Trust, Medical Research Council (MRC) and/or Alzheimer’s Research UK (ARUK) and the Welsh Assembly Government.

UR - http://www.scopus.com/inward/record.url?scp=85094221565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85094221565&partnerID=8YFLogxK

U2 - 10.1038/s41380-019-0373-9

DO - 10.1038/s41380-019-0373-9

M3 - Comment/debate

C2 - 30862939

AN - SCOPUS:85094221565

SN - 1359-4184

VL - 25

SP - 3109

EP - 3111

JO - Molecular psychiatry

JF - Molecular psychiatry

IS - 11

ER -

Correction: Genetic risk for schizophrenia and psychosis in Alzheimer disease (Molecular Psychiatry, (2018), 23, 4, (963-972), 10.1038/mp.2017.81)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this